$TNXP News Article - Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)
https://marketwirenews.com/news-releases/toni...39328.html